Hepatitis C identification and management by family physicians

Family Medicine

Volumn 37, Issue 9, 2005, Pages 644-649

  Clark, Elizabeth C ^a   Yawn, Barbara P ^b   Galliher, James M ^c   Temte, Jonathan L ^d   Hickner, John ^c,e  

^a UNIVERSITY OF IOWA   (United States)

^b OLMSTED MEDICAL CENTER   (United States)

^c AMERICAN ACADEMY OF FAMILY PHYSICIANS   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

^e UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; FEMALE; GENERAL PRACTITIONER; HEALTH SURVEY; HEPATITIS C; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT REFERRAL; PRESCRIPTION;

ADULT; AGED; ANTIBODIES, VIRAL; ANTIVIRAL AGENTS; FAMILY PRACTICE; FEMALE; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; PATIENT EDUCATION; PHYSICIAN'S ROLE; PRACTICE GUIDELINES; PROFESSIONAL PRACTICE; REFERRAL AND CONSULTATION; RISK ASSESSMENT; RISK FACTORS; UNITED STATES;

EID: 26644462399     PISSN: 07423225     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Morb Mortal Wkly Rep 1998;47(RR19):1-39.
2. Alter MJ, Rruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999;341(8):556-62.
3. Singer ME, Younossi ZM. Cost-effectiveness of screening for hepatitis C virus in asymptomatic, average-risk adults. Am J Med 2001;111(8): 614-21.
4. Gordon FD. Cost-effectiveness of screening patients for hepatitis C. Am J Med 1999;107(6B):36S-40S.
5. Yawn BP, Wollan P, Gazzuola L, Kim WR. Diagnosis and 10-year follow-up of a community-based hepatitis C cohort. J Fam Pract 2002;51(2):135-40.
6. Rocca L, Yawn BP, Wollan P, Kim WR. Management of patients with hepatitis C in a community population: diagnosis, discussions, and decisions to treat. Ann Fam Med 2004;2(2):116-24.
7. Future of Family Medicine Project Leadership Committee. The Future of Family Medicine: a collaborative project of the family medicine community. Ann Fam Med 2004;2(suppl 1):S3-S32.
8. Dillman DA. Mail and Internet surveys: the tailored design method, second edition. New York: John Wiley & Sons, 2000.
9. Shehab TM, Sonnad SS, Lok ASF. Management of hepatitis C patients by primary care physicians in the USA: results of a national survey. J Viral Hepat 2001;8:377-83.
10. Shehab TM, Sonnad SS, Jeffries M, Gunaratnum N, Lok ASF. Current practice patterns of primary care physicians in the management of patients with hepatitis C. Hepatology 1999;30:794-800.
11. Cashman TM, Elm JL, Wu M, Tom T, Effler PV. Hepatitis C, diagnosis and management: a survey of practicing physicians in Hawaii. Hawaii Med J 2001;60:148-52.
12. Frame P. Health maintenance in clinical practice: strategies and barriers. Am Fam Physician 1992;45(3):1192-200.
13. Anonymous. National Institutes of Health Consensus Development Conference Panel statement: management of hepatitis C. Hepatology 1997;26(3 suppl 1):2S-10S.
14. Booth J, O'Grady J, Neuberger J. Clinical guidlines on the management of hepatitis C. Gut 2001;49(suppl I):I1-I21.
15. Bacon B. Treatment of patients with hepatitis C and normal serum aminotransferase levels. Hepatology 2002;36(5 suppl 1):S161-S184.
16. Chou R, Clark EC, Helfand M. Screening for hepatitis C virus infection: a review of the evidence for the US Preventive Services Task Force. Ann Intern Med 2004;140(6):465-79.
17. Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infections. N Engl J Med 2002;347(13):975-82.
18. Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001;358(9286):958-65.
19. Chander G, Sulkowski MS, Jenckes MW, et al. Treatment of chronic hepatitis C: a systematic review. Hepatology 2002;36(5 suppl 1):S135-S144.
20. Montano D, Phillips W. Cancer screening by primary care physicians: a comparison of rates obtained from physician self-report, patient survey, and chart audit. Am J Public Health 1995;85(6):795-800.
21. Groves RM, Cialdini RB, Couper MP. Understanding the decision to participate in a survey. Public Opin Q 1992;56:475-95.
22. Steeb C. Trends in nonresponse rates. Public Opin Q 1981;45:40-57.